Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cascadian Therapeutics, Inc. (ONTY) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cascadian Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1412067.
Total stock buying since 2014: $1,178,571.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2018 | 0 | $0 | 0 | $0 | 20,925 | $0 |
| 2017 | 81,790 | $329,284 | 0 | $0 | 68,038 | $0 |
| 2016 | 107,500 | $101,749 | 0 | $0 | 0 | $0 |
| 2015 | 25,747 | $58,853 | 0 | $0 | 49,425 | $0 |
| 2014 | 378,444 | $688,685 | 0 | $0 | 16,042 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2018-01 | 0 | $0 | 0 | $0 | 20,925 | $0 |
| 2017-09 | 0 | $0 | 0 | $0 | 9,500 | $0 |
| 2017-08 | 5,500 | $20,542 | 0 | $0 | 0 | $0 |
| 2017-06 | 0 | $0 | 0 | $0 | 53,882 | $0 |
| 2017-05 | 2,800 | $11,191 | 0 | $0 | 0 | $0 |
| 2017-03 | 4,666 | $19,012 | 0 | $0 | 4,656 | $0 |
| 2017-02 | 23,000 | $97,520 | 0 | $0 | 0 | $0 |
| 2017-01 | 45,824 | $181,019 | 0 | $0 | 0 | $0 |
| 2016-08 | 45,000 | $51,749 | 0 | $0 | 0 | $0 |
| 2016-06 | 62,500 | $50,000 | 0 | $0 | 0 | $0 |
| 2015-09 | 0 | $0 | 0 | $0 | 17,341 | $0 |
| 2015-06 | 5,747 | $26,723 | 0 | $0 | 32,084 | $0 |
| 2015-03 | 20,000 | $32,130 | 0 | $0 | 0 | $0 |
| 2014-12 | 378,444 | $688,685 | 0 | $0 | 0 | $0 |
| 2014-06 | 0 | $0 | 0 | $0 | 16,042 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-01-11 | Walker Luke Nathaniel (SVP, Clinical Development) | Option Ex | 1,950 | .00 | 0 |
| 2018-01-11 | Peterson Scott Robert (Chief Scientific Officer) | Option Ex | 2,825 | .00 | 0 |
| 2018-01-11 | Eastland Julia Marie (CFO & CBO) | Option Ex | 2,825 | .00 | 0 |
| 2018-01-11 | Christianson Gary (Chief Operating Officer) | Option Ex | 2,825 | .00 | 0 |
| 2018-01-11 | Myers Scott Dunseth (President and CEO) | Option Ex | 10,500 | .00 | 0 |
| 2017-09-24 | James Steven P (Director) | Option Ex | 2,375 | .00 | 0 |
| 2017-09-24 | Henney Christopher S (Director) | Option Ex | 2,375 | .00 | 0 |
| 2017-09-24 | Spiegelman Daniel K (Director) | Option Ex | 2,375 | .00 | 0 |
| 2017-09-24 | Love Ted W (Director) | Option Ex | 2,375 | .00 | 0 |
| 2017-08-11 | Myers Scott Dunseth (President and CEO) | Buy | 5,500 | 3.73 | 20,542 |
| 2017-06-24 | Fyfe Gwen A. (Director) | Option Ex | 9,058 | .00 | 0 |
| 2017-06-24 | James Steven P (Director) | Option Ex | 9,058 | .00 | 0 |
| 2017-06-24 | Henney Christopher S (Director) | Option Ex | 9,058 | .00 | 0 |
| 2017-06-24 | Spiegelman Daniel K (Director) | Option Ex | 9,058 | .00 | 0 |
| 2017-06-24 | Love Ted W (Director) | Option Ex | 9,058 | .00 | 0 |
| 2017-06-12 | James Steven P (Director) | Option Ex | 2,148 | .00 | 0 |
| 2017-06-12 | Henney Christopher S (Director) | Option Ex | 2,148 | .00 | 0 |
| 2017-06-12 | Spiegelman Daniel K (Director) | Option Ex | 2,148 | .00 | 0 |
| 2017-06-12 | Love Ted W (Director) | Option Ex | 2,148 | .00 | 0 |
| 2017-05-12 | Myers Scott Dunseth (President and CEO) | Buy | 2,800 | 4.00 | 11,191 |
| 2017-03-31 | Myers Scott Dunseth (President and CEO) | Buy | 2,000 | 4.11 | 8,228 |
| 2017-03-28 | Fyfe Gwen A. (Director) | Buy | 1,666 | 4.12 | 6,857 |
| 2017-03-20 | Myers Scott Dunseth (President and CEO) | Buy | 1,000 | 3.93 | 3,927 |
| 2017-03-12 | James Steven P (Director) | Option Ex | 4,656 | .00 | 0 |
| 2017-02-02 | Love Ted W (Director) | Buy | 23,000 | 4.24 | 97,520 |
| 2017-01-30 | Henney Christopher S (Director) | Buy | 25,324 | 4.11 | 103,980 |
| 2017-01-27 | Myers Scott Dunseth (President and CEO) | Buy | 20,500 | 3.76 | 77,039 |
| 2016-08-17 | Myers Scott Dunseth (President and CEO) | Buy | 45,000 | 1.15 | 51,749 |
| 2016-06-28 | Myers Scott Dunseth (President and CEO) | Buy | 62,500 | .80 | 50,000 |
| 2015-09-05 | Love Ted W (Director) | Option Ex | 17,341 | .00 | 0 |
| 2015-06-13 | Jackson Richard L. (Director) | Option Ex | 16,042 | .00 | 0 |
| 2015-06-13 | Spiegelman Daniel K (Director) | Option Ex | 16,042 | .00 | 0 |
| 2015-06-01 | Hausman Diana (Chief Medical Officer) | Buy | 5,747 | 4.65 | 26,723 |
| 2015-03-26 | Spiegelman Daniel K (Director) | Buy | 10,000 | 1.59 | 15,860 |
| 2015-03-25 | Spiegelman Daniel K (Director) | Buy | 10,000 | 1.63 | 16,270 |
| 2014-12-17 | Lampert Mark N | Buy | 153,495 | 1.73 | 266,006 |
| 2014-12-15 | Lampert Mark N | Buy | 224,949 | 1.88 | 422,679 |
| 2014-06-13 | Henney Christopher S (Director) | Option Ex | 16,042 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of ONTY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cascadian Therapeutics, Inc. (symbol ONTY, CIK number 1412067) see the Securities and Exchange Commission (SEC) website.